 SILVER SPRING, Md., March 01, 2021 GLOBE NEWSWIRE -- Aziyo Biologics, Inc. Nasdaq: AZYO, a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the fourth quarter and full year ended December 31, 2020. 